{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T03:58:58Z","timestamp":1774670338845,"version":"3.50.1"},"reference-count":95,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,6,1]],"date-time":"2012-06-01T00:00:00Z","timestamp":1338508800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R01 GM087650"],"award-info":[{"award-number":["R01 GM087650"]}]},{"DOI":"10.13039\/100000057","name":"National Institute of General Medical Sciences (NIGMS)","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100000057","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Thomas Jefferson University Department of Biochemistry"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Cell & Developmental Biology"],"published-print":{"date-parts":[[2012,6]]},"DOI":"10.1016\/j.semcdb.2012.01.016","type":"journal-article","created":{"date-parts":[[2012,1,30]],"date-time":"2012-01-30T21:41:22Z","timestamp":1327959682000},"page":"465-472","source":"Crossref","is-referenced-by-count":102,"title":["Therapeutic approaches to modulating Notch signaling: Current challenges and future prospects"],"prefix":"10.1016","volume":"23","author":[{"given":"Casper","family":"Groth","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark E.","family":"Fortini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.semcdb.2012.01.016_bib0005","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1086\/279446","article-title":"The analysis of a case of continuous variation in Drosophila by a study of its linkage relations","volume":"48","author":"Dexter","year":"1914","journal-title":"Am Nat"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0010","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/0092-8674(91)90111-B","article-title":"TAN-1, the human homolog of the Drosophila Notch gene, is broken by chromosomal translocations in T lymphoblastic neoplasms","volume":"66","author":"Ellisen","year":"1991","journal-title":"Cell"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0015","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1126\/science.1102160","article-title":"Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia","volume":"306","author":"Weng","year":"2004","journal-title":"Science"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0020","doi-asserted-by":"crossref","first-page":"398","DOI":"10.2174\/138920310791824039","article-title":"Notch signaling proteins: legitimate targets for cancer therapy","volume":"11","author":"Wang","year":"2010","journal-title":"Curr Protein Pept Sci"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0025","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.semcdb.2008.10.007","article-title":"Structure and function of \u03b3-secretase","volume":"20","author":"Tolia","year":"2009","journal-title":"Semin Cell Dev Biol"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0030","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1021\/jm970621b","article-title":"A substrate-based difluoro ketone selectively inhibits Alzheimer's \u03b3-secretase activity","volume":"41","author":"Wolfe","year":"1998","journal-title":"J Med Chem"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0035","doi-asserted-by":"crossref","first-page":"6138","DOI":"10.1073\/pnas.110126897","article-title":"Presenilin 1 is linked with \u03b3-secretase activity in the detergent solubilized state","volume":"97","author":"Li","year":"2000","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0040","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1021\/jm049788c","article-title":"Discovery of a subnanomolar helical D-tridecapeptide inhibitor of \u03b3-secretase","volume":"47","author":"Bihel","year":"2004","journal-title":"J Med Chem"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0045","doi-asserted-by":"crossref","first-page":"34086","DOI":"10.1074\/jbc.M005430200","article-title":"Presenilin-1 and -2 are molecular targets for \u03b3-secretase inhibitors","volume":"275","author":"Seiffert","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0050","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1046\/j.1471-4159.2001.00012.x","article-title":"Functional \u03b3-secretase inhibitors reduce \u03b2-amyloid peptide levels in brain","volume":"76","author":"Dovey","year":"2001","journal-title":"J Neurochem"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0055","first-page":"S133","article-title":"Chronic treatment with a functional \u03b3-secretase inhibitor reduces A\u03b2 burden and plaque pathology in PDAPP mice","volume":"23","author":"May","year":"2002","journal-title":"Neurobiol Aging"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0060","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1124\/jpet.106.110700","article-title":"Concentration-dependent modulation of amyloid-\u03b2 in vivo and in vitro using the \u03b3-secretase inhibitor, LY-450139","volume":"319","author":"Lanz","year":"2006","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0065","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1471-4159.2011.07501.x","article-title":"\u03b3-Secretase inhibitors and modulators for Alzheimer's disease","volume":"120","author":"Wolfe","year":"2012","journal-title":"J Neurochem"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0070","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2011.01.002","article-title":"Anti-A\u03b2 therapeutics in Alzheimer's disease: the need for a paradigm shift","volume":"69","author":"Golde","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0075","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1038\/nrd3505","article-title":"The amyloid cascade hypothesis for Alzheimer's disease: an appraisal for the development of therapeutics","volume":"10","author":"Karran","year":"2011","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0080","doi-asserted-by":"crossref","first-page":"46107","DOI":"10.1074\/jbc.M307757200","article-title":"Adipsin, a biomarker of gastrointestinal toxicity mediated by a functional \u03b3-secretase inhibitor","volume":"278","author":"Searfoss","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0085","doi-asserted-by":"crossref","first-page":"12876","DOI":"10.1074\/jbc.M311652200","article-title":"Chronic treatment with the \u03b3-secretase inhibitor LY-411,575 inhibits \u03b2-amyloid peptide production and alters lymphopoiesis and intestinal cell differentiation","volume":"279","author":"Wong","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0090","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/nature03659","article-title":"Notch\/\u03b3-secretase inhibition turns proliferative cells in intestinal crypts and adenomas into goblet cells","volume":"435","author":"van Es","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0095","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1128\/MCB.01655-05","article-title":"Leukemia-associated mutations within the NOTCH1 heterodimerization domain fall into at least two distinct mechanistic classes","volume":"26","author":"Malecki","year":"2006","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0100","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1182\/blood-2007-12-130096","article-title":"NOTCH1 extracellular juxtamembrane expansion mutations in T-ALL","volume":"112","author":"Sulis","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0105","doi-asserted-by":"crossref","first-page":"6964","DOI":"10.1158\/1078-0432.CCR-07-1474","article-title":"Notch-1 mutations are secondary events in some patients with T-cell acute lymphoblastic leukemia","volume":"13","author":"Mansour","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0110","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/sj.leu.2404258","article-title":"CUTLL1, a novel human T-cell lymphoma cell line with t(7;9) rearrangement, aberrant NOTCH1 activation and high sensitivity to \u03b3-secretase inhibitors","volume":"20","author":"Palomero","year":"2006","journal-title":"Leukemia"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0115","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1182\/blood-2005-06-2553","article-title":"Activating Notch1 mutations in mouse models of T-ALL","volume":"107","author":"O\u2019Neil","year":"2006","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0120","first-page":"77","article-title":"\u03b3-Secretase inhibitors suppress the growth of leukemia and lymphoma cells","volume":"18","author":"Kogoshi","year":"2007","journal-title":"Oncol Rep"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0125","doi-asserted-by":"crossref","first-page":"533","DOI":"10.3324\/haematol.11894","article-title":"In vitro validation of \u03b3-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia","volume":"93","author":"De Keersmaecker","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0130","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1158\/1535-7163.MCT-10-0034","article-title":"Evaluation of selective \u03b3-secretase inhibitor PF-03084014 for its antitumor efficacy and gastrointestinal safety to guide optimal clinical trial design","volume":"9","author":"Wei","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0135","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.chembiol.2006.12.010","article-title":"Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of Notch signaling","volume":"14","author":"Lewis","year":"2007","journal-title":"Chem Biol"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0140","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1084\/jem.20070876","article-title":"FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to \u03b3-secretase inhibitors","volume":"204","author":"O\u2019Neil","year":"2007","journal-title":"J Exp Med"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0145","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1111\/j.1476-5381.2009.00389.x","article-title":"Down-regulation of the Notch pathway mediated by a \u03b3-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia","volume":"158","author":"Tammam","year":"2009","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0150","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.22741","article-title":"Initial testing (stage 1) by the pediatric preclinical testing program of RO4929097, a \u03b3-secretase inhibitor targeting Notch signaling","author":"Kolb","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0155","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/nm1636","article-title":"Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia","volume":"13","author":"Palomero","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0160","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1093\/toxsci\/kfh254","article-title":"Modulation of Notch processing by \u03b3-secretase inhibitors causes intestinal goblet cell metaplasia and induction of genes known to specify gut secretory lineage differentiation","volume":"82","author":"Milano","year":"2004","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0165","doi-asserted-by":"crossref","first-page":"6585","DOI":"10.1200\/jco.2006.24.18_suppl.6585","article-title":"A phase I clinical trial of the Notch inhibitor MK-0752 in patients with T-cell acute lymphoblastic leukemia\/lymphoma (T-ALL) and other leukemias","volume":"24","author":"Deangelo","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0170","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1182\/blood.V99.10.3742","article-title":"Notch2 is involved in the overexpression of CD23 in B-cell chronic lymphocytic leukemia","volume":"99","author":"Hubmann","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0175","doi-asserted-by":"crossref","first-page":"3398","DOI":"10.1182\/blood.V99.9.3398","article-title":"Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma","volume":"99","author":"Jundt","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0180","doi-asserted-by":"crossref","first-page":"3511","DOI":"10.1182\/blood-2003-07-2254","article-title":"Jagged1-induced Notch signaling drives proliferation of multiple myeloma cells","volume":"103","author":"Jundt","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0185","doi-asserted-by":"crossref","first-page":"3503","DOI":"10.1182\/blood-2003-07-2340","article-title":"Involvement of Notch-1 signaling in bone marrow stroma-mediated de novo drug resistance of myeloma and other malignant lymphoid cell lines","volume":"103","author":"Nefedova","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0190","doi-asserted-by":"crossref","first-page":"36523","DOI":"10.1074\/jbc.M006415200","article-title":"Cell cycle arrest and apoptosis induced by Notch1 in B cells","volume":"275","author":"Morimura","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0195","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1038\/sj.cdd.4401253","article-title":"Notch1 enhances B-cell receptor-induced apoptosis in mature activated B cells without affecting cell cycle progression and surface IgM expression","volume":"10","author":"Romer","year":"2003","journal-title":"Cell Death Differ"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0200","doi-asserted-by":"crossref","first-page":"3898","DOI":"10.1182\/blood-2005-01-0355","article-title":"Notch signaling is a potent inducer of growth arrest and apoptosis in a wide range of B-cell malignancies","volume":"106","author":"Zweidler-McKay","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0205","doi-asserted-by":"crossref","first-page":"3697","DOI":"10.1182\/blood-2003-12-4114","article-title":"Overexpression of the NOTCH ligand JAG2 in malignant plasma cells from multiple myeloma patients and cell lines","volume":"104","author":"Houde","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0210","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1038\/leu.2008.138","article-title":"Notch inhibition blocks multiple myeloma cell-induced osteoclast activation","volume":"22","author":"Schwarzer","year":"2008","journal-title":"Leukemia"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0215","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/j.leukres.2006.05.003","article-title":"Establishment of a novel B-cell lymphoma cell line with suppressed growth by \u03b3-secretase inhibitors","volume":"30","author":"Tohda","year":"2006","journal-title":"Leuk Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0220","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1038\/leu.2011.50","article-title":"GSI-I (Z-LLNle-CHO) inhibits \u03b3-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia","volume":"25","author":"Meng","year":"2011","journal-title":"Leukemia"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0225","doi-asserted-by":"crossref","first-page":"R57","DOI":"10.1186\/bcr2347","article-title":"The cytotoxicity of \u03b3-secretase inhibitor I to breast cancer cells is mediated by proteasome inhibition, not by \u03b3-secretase inhibition","volume":"11","author":"Han","year":"2009","journal-title":"Breast Cancer Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0230","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1182\/blood-2007-07-102632","article-title":"Inhibition of Notch signaling induces apoptosis of myeloma cells and enhances sensitivity to chemotherapy","volume":"111","author":"Nefedova","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1101\/gad.6.3.345","article-title":"Expression of an activated Notch-related int-3 transgene interferes with cell differentiation and induces neoplastic transformation in mammary and salivary glands","volume":"6","author":"Jhappan","year":"1992","journal-title":"Genes Dev"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0240","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1038\/sj.onc.1201035","article-title":"The mouse mammary tumor associated gene INT3 is a unique member of the NOTCH gene family (NOTCH4)","volume":"14","author":"Gallahan","year":"1997","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0245","doi-asserted-by":"crossref","first-page":"5973","DOI":"10.1038\/sj.onc.1202991","article-title":"Involvement of Notch1 in the development of mouse mammary tumors","volume":"18","author":"Dievart","year":"1999","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0250","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.onc.1203295","article-title":"Identification of a novel NOTCH-4\/INT-3 RNA species encoding an activated gene product in certain human tumor cell lines","volume":"19","author":"Imatani","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0255","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0002-9440(10)63333-0","article-title":"Modulation of Notch signaling elicits signature tumors and inhibits hras1-induced oncogenesis in the mouse mammary epithelium","volume":"165","author":"Kiaris","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0260","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1038\/nm754","article-title":"Activation of Notch-1 signaling maintains the neoplastic phenotype in human Ras-transformed cells","volume":"8","author":"Weijzen","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0265","doi-asserted-by":"crossref","first-page":"8530","DOI":"10.1158\/0008-5472.CAN-05-1069","article-title":"High-level coexpression of JAG1 and NOTCH1 is observed in human breast cancer and is associated with poor overall survival","volume":"65","author":"Reedijk","year":"2005","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0270","first-page":"779","article-title":"The possible correlation of Notch-1 and Notch-2 with clinical outcome and tumour clinicopathological parameters in human breast cancer","volume":"14","author":"Parr","year":"2004","journal-title":"Int J Mol Med"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0275","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1158\/0008-5472.CAN-05-3054","article-title":"Aberrant activation of Notch signaling in human breast cancer","volume":"66","author":"Stylianou","year":"2006","journal-title":"Cancer Res"},{"issue":"Suppl. 1","key":"10.1016\/j.semcdb.2012.01.016_bib0280","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1046\/j.1365-2184.36.s.1.6.x","article-title":"Stem cells in normal breast development and breast cancer","volume":"36","author":"Dontu","year":"2003","journal-title":"Cell Prolif"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0285","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1038\/sj.emboj.7600069","article-title":"Integration of TGF-\u03b2\/Smad and Jagged1\/Notch signalling in epithelial-to-mesenchymal transition","volume":"23","author":"Zavadil","year":"2004","journal-title":"EMBO J"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0290","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.semcancer.2004.04.015","article-title":"Notch in lung development and lung cancer","volume":"14","author":"Collins","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0295","first-page":"3200","article-title":"Notch signaling induces cell cycle arrest in small cell lung cancer cells","volume":"61","author":"Sriuranpong","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0300","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1093\/jnci\/92.16.1355","article-title":"Chromosome 19 translocation, overexpression of Notch3, and human lung cancer","volume":"92","author":"Dang","year":"2000","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0305","doi-asserted-by":"crossref","first-page":"5355","DOI":"10.1073\/pnas.94.10.5355","article-title":"Conservation of the Drosophila lateral inhibition pathway in human lung cancer: a hairy-related protein (HES-1) directly represses achaete-scute homolog-1 expression","volume":"94","author":"Chen","year":"1997","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0310","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1038\/sj.onc.1206230","article-title":"Constitutive activation of Notch3 inhibits terminal epithelial differentiation in lungs of transgenic mice","volume":"22","author":"Dang","year":"2003","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0315","doi-asserted-by":"crossref","first-page":"8051","DOI":"10.1158\/0008-5472.CAN-07-1022","article-title":"\u03b3-Secretase inhibitor prevents Notch3 activation and reduces proliferation in human lung cancers","volume":"67","author":"Konishi","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0320","doi-asserted-by":"crossref","first-page":"5124","DOI":"10.1038\/onc.2008.226","article-title":"Rational targeting of Notch signaling in cancer","volume":"27","author":"Rizzo","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0325","doi-asserted-by":"crossref","first-page":"6333","DOI":"10.1038\/sj.onc.1208783","article-title":"\u03b3-Secretase inhibitor blocks Notch activation and induces apoptosis in Kaposi's sarcoma tumor cells","volume":"24","author":"Curry","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0330","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/CAD.0b013e3282fc6cdd","article-title":"Inhibition of \u03b3-secretase affects proliferation of leukemia and hepatoma cell lines through Notch signaling","volume":"19","author":"Suwanjunee","year":"2008","journal-title":"Anticancer Drugs"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0335","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1053\/j.gastro.2009.01.008","article-title":"Inhibition of \u03b3-secretase activity inhibits tumor progression in a mouse model of pancreatic ductal adenocarcinoma","volume":"136","author":"Plentz","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0340","doi-asserted-by":"crossref","first-page":"7672","DOI":"10.1158\/0008-5472.CAN-09-1843","article-title":"Preclinical profile of a potent \u03b3-secretase inhibitor targeting Notch signaling with in vivo efficacy and pharmacodynamic properties","volume":"69","author":"Luistro","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0345","doi-asserted-by":"crossref","first-page":"7445","DOI":"10.1158\/0008-5472.CAN-06-0858","article-title":"Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors","volume":"66","author":"Fan","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0350","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/nm.1900","article-title":"\u03b3-Secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia","volume":"15","author":"Real","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0355","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/bjc.2011.321","article-title":"Targeting both Notch and ErbB-2 signalling pathways is required for prevention of ErbB-2-positive breast tumour recurrence","volume":"105","author":"Pandya","year":"2011","journal-title":"Br J Cancer"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0360","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1038\/onc.2008.149","article-title":"ErbB-2 inhibition activates Notch-1 and sensitizes breast cancer cells to a \u03b3-secretase inhibitor","volume":"27","author":"Osipo","year":"2008","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0365","doi-asserted-by":"crossref","first-page":"3441","DOI":"10.1038\/sj.emboj.7601761","article-title":"Notch-induced T cell development requires phosphoinositide-dependent kinase 1","volume":"26","author":"Kelly","year":"2007","journal-title":"EMBO J"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0370","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1158\/0008-5472.CAN-08-3478","article-title":"Notch activation induces Akt signaling via an autocrine loop to prevent apoptosis in breast epithelial cells","volume":"69","author":"Meurette","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0375","doi-asserted-by":"crossref","first-page":"2476","DOI":"10.1158\/0008-5472.CAN-09-3114","article-title":"Downregulation of Notch pathway by a \u03b3-secretase inhibitor attenuates AKT\/mammalian target of rapamycin signaling and glucose uptake in an ERBB2 transgenic breast cancer model","volume":"70","author":"Efferson","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0380","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1158\/0008-5472.CAN-08-2088","article-title":"\u03b3-Secretase inhibitors abrogate oxaliplatin-induced activation of the Notch-1 signaling pathway in colon cancer cells resulting in enhanced chemosensitivity","volume":"69","author":"Meng","year":"2009","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0385","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1158\/1535-7163.MCT-10-0372","article-title":"Combined inhibition of Notch signaling and Bcl-2\/Bcl-xL results in synergistic antimyeloma effect","volume":"9","author":"Li","year":"2010","journal-title":"Mol Cancer Ther"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0390","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s13402-011-0060-6","article-title":"\u03b3-Secretase inhibitor enhances the cytotoxic effect of bortezomib in multiple myeloma","volume":"34","author":"Chen","year":"2011","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0395","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/1476-4598-10-138","article-title":"Targeting Notch pathway enhances rapamycin antitumor activity in pancreas cancers through PTEN phosphorylation","volume":"10","author":"Vo","year":"2011","journal-title":"Mol Cancer"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0400","doi-asserted-by":"crossref","first-page":"8046","DOI":"10.1074\/jbc.M800170200","article-title":"Modulation of Notch signaling by antibodies specific for the extracellular negative regulatory region of NOTCH3","volume":"283","author":"Li","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0405","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1038\/nature08878","article-title":"Therapeutic antibody targeting of individual Notch receptors","volume":"464","author":"Wu","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0410","doi-asserted-by":"crossref","first-page":"e9094","DOI":"10.1371\/journal.pone.0009094","article-title":"Characterization of Notch1 antibodies that inhibit signaling of both normal and mutated Notch1 receptors","volume":"5","author":"Aste-Am\u00e9zaga","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0415","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.4049\/jimmunol.179.9.5990","article-title":"Jagged1 and Delta1 differentially regulate the outcome of experimental autoimmune encephalomyelitis","volume":"179","author":"Elyaman","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0420","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.stem.2009.05.019","article-title":"DLL4 blockade inhibits tumor growth and reduces tumor-initiating cell frequency","volume":"5","author":"Hoey","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0425","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1158\/0008-5472.CAN-10-2817","article-title":"Anti-DLL4 inhibits growth and reduces tumor-initiating cell frequency in colorectal tumors with oncogenic KRAS mutations","volume":"71","author":"Fischer","year":"2011","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0430","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature08543","article-title":"Direct inhibition of the NOTCH transcription factor complex","volume":"462","author":"Moellering","year":"2009","journal-title":"Nature"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0435","article-title":"Neutralization of the \u03b3-secretase activity by monoclonal antibody against extracellular domain of nicastrin","author":"Hayashi","year":"2011","journal-title":"Oncogene"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0440","doi-asserted-by":"crossref","first-page":"4727","DOI":"10.1158\/0008-5472.CAN-07-6499","article-title":"A Notch1 ectodomain construct inhibits endothelial Notch signaling, tumor growth, and angiogenesis","volume":"68","author":"Funahashi","year":"2008","journal-title":"Cancer Res"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0445","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/138920108783497613","article-title":"ADAM10 as a target for anti-cancer therapy","volume":"9","author":"Moss","year":"2008","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0450","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1128\/MCB.23.2.655-664.2003","article-title":"Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of Notch signaling","volume":"23","author":"Weng","year":"2003","journal-title":"Mol Cell Biol"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0455","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1182\/blood-2004-02-0514","article-title":"Mastermind critically regulates Notch-mediated lymphoid cell fate decisions","volume":"104","author":"Maillard","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0460","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1002\/art.27626","article-title":"Targeting ADAM-17\/Notch signaling abrogates the development of systemic sclerosis in a murine model","volume":"62","author":"Kavian","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0465","first-page":"131","article-title":"Some biological and practical aspects of growth","volume":"17","author":"Jacobs","year":"1916","journal-title":"Univ Bull Univ Penn"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0470","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1124\/jpet.110.167379","article-title":"Pharmacodynamics and pharmacokinetics of the \u03b3-secretase inhibitor PF-3084014","volume":"334","author":"Lanz","year":"2010","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/j.semcdb.2012.01.016_bib0475","doi-asserted-by":"crossref","first-page":"3529","DOI":"10.1200\/JCO.2011.35.7806","article-title":"Phase I trial of MK-0752 in children with refractory CNS malignancies: a pediatric brain tumor consortium study","volume":"29","author":"Fouladi","year":"2011","journal-title":"J Clin Oncol"}],"container-title":["Seminars in Cell & Developmental Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952112000262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1084952112000262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T11:58:02Z","timestamp":1593604682000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1084952112000262"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,6]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,6]]}},"alternative-id":["S1084952112000262"],"URL":"https:\/\/doi.org\/10.1016\/j.semcdb.2012.01.016","relation":{},"ISSN":["1084-9521"],"issn-type":[{"value":"1084-9521","type":"print"}],"subject":[],"published":{"date-parts":[[2012,6]]}}}